Regenxbio Inc (RGNX) — Cash Flow-to-Debt Ratio
Regenxbio Inc (RGNX) has a Cash Flow-to-Debt Ratio of -0.15x as of September 2025, meaning its operating cash flow of $-55.96 Million could theoretically repay 0% of its total liabilities ($363.75 Million) in one year. See Regenxbio Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Regenxbio Inc Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Regenxbio Inc across 12 annual periods. Also explore net asset growth rate of Regenxbio Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Regenxbio Inc (2013–2024)
Year-by-year debt coverage analysis for Regenxbio Inc. For market capitalisation and broader financial context, see Regenxbio Inc stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.84x | $-173.12 Million | $206.34 Million | ▼ -0.7% |
| 2023 | -0.83x | $-218.41 Million | $262.23 Million | ▼ -27.3% |
| 2022 | -0.65x | $-207.49 Million | $317.07 Million | ▼ -204.5% |
| 2021 | 0.63x | $218.88 Million | $349.61 Million | ▲ +482.6% |
| 2020 | -0.16x | $-54.06 Million | $330.41 Million | ▲ +92.8% |
| 2019 | -2.26x | $-107.70 Million | $47.71 Million | ▼ -175.4% |
| 2018 | 2.99x | $104.65 Million | $34.97 Million | ▲ +180.8% |
| 2017 | -3.71x | $-57.99 Million | $15.65 Million | ▲ +16.1% |
| 2016 | -4.42x | $-48.56 Million | $10.99 Million | ▲ +10.3% |
| 2015 | -4.92x | $-22.52 Million | $4.57 Million | ▼ -1786.3% |
| 2014 | -0.26x | $-2.40 Million | $9.19 Million | ▲ +59.7% |
| 2013 | -0.65x | $-3.01 Million | $4.65 Million | — |